Literature DB >> 20960184

Effects of 1,2,4,6-tetra-O-galloyl-β-D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2.2.15 cell culture.

Yang-Fei Xiang1, Huai-Qiang Ju, Shen Li, Ying-Jun Zhang, Chong-Ren Yang, Yi-Fei Wang.   

Abstract

A polyphenolic compound, 1,2,4,6-tetra-O-galloyl-β-D-glucose (1246TGG), was isolated from the traditional Chinese medicine Phyllanthus emblica L. (Euphorbiaceae) and assayed for its potential as an anti-hepatitis B virus (HBV) agent. The cytotoxicity of 1246TGG on HepG2.2.15 as well as HepG2 cells was determined by observing cytopathic effects, and the effects of 1246TGG on secretion of HBsAg and HBeAg in HepG2.2.15 cells were assayed by enzyme immunoassay. Results indicates that treatment with 1246TGG (6.25 μg/mL, 3.13 μg/mL), reduced both HBsAg and HBeAg levels in culture supernatant, yet the inhibitory effects tend to decline with the assay time. This study provides a basis for further investigation of the anti-HBV activity and possible mechanism of action of 1246TGG.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960184      PMCID: PMC7090425          DOI: 10.1007/s12250-010-3144-y

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  16 in total

1.  Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica.

Authors:  Y J Zhang; T Abe; T Tanaka; C R Yang; I Kouno
Journal:  J Nat Prod       Date:  2001-12       Impact factor: 4.050

Review 2.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

Review 3.  [Ethnopharmacology of Phyllanthus emblica L].

Authors:  Q Xia; P Xiao; L Wan; J Kong
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  1997-09

4.  Inhibition of herpes simplex virus infection by tannins and related compounds.

Authors:  K Fukuchi; H Sakagami; T Okuda; T Hatano; S Tanuma; K Kitajima; Y Inoue; S Inoue; S Ichikawa; M Nonoyama
Journal:  Antiviral Res       Date:  1989 Jun-Jul       Impact factor: 5.970

5.  Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase.

Authors:  S el-Mekkawy; M R Meselhy; I T Kusumoto; S Kadota; M Hattori; T Namba
Journal:  Chem Pharm Bull (Tokyo)       Date:  1995-04       Impact factor: 1.645

6.  Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.

Authors:  Allan Lançon; Nathalie Hanet; Brigitte Jannin; Dominique Delmas; Jean-Marie Heydel; Gérard Lizard; Marie-Christine Chagnon; Yves Artur; Norbert Latruffe
Journal:  Drug Metab Dispos       Date:  2007-02-07       Impact factor: 3.922

7.  Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process.

Authors:  A Lançon; D Delmas; H Osman; J-P Thénot; B Jannin; N Latruffe
Journal:  Biochem Biophys Res Commun       Date:  2004-04-16       Impact factor: 3.575

Review 8.  Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review.

Authors:  Lingyi Zhang; Guqi Wang; Weihong Hou; Ping Li; Andrea Dulin; Herbert L Bonkovsky
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

9.  Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease.

Authors:  Deliang Duan; Zhengquan Li; Hongpeng Luo; Wei Zhang; Lirong Chen; Xiaojie Xu
Journal:  Bioorg Med Chem Lett       Date:  2004-12-20       Impact factor: 2.823

10.  Sulfated pentagalloyl glucose (Y-ART-3) inhibits HIV replication and cytopathic effects in vitro, and reduces HIV infection in hu-PBL-SCID mice.

Authors:  H Nakashima; K Ichiyama; F Hirayama; K Uchino; M Ito; T Saitoh; M Ueki; N Yamamoto; H Ogawara
Journal:  Antiviral Res       Date:  1996-05       Impact factor: 10.103

View more
  8 in total

1.  Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.

Authors:  Mohamed Haddad; Roger Gaudreault; Gabriel Sasseville; Phuong Trang Nguyen; Hannah Wiebe; Theo Van De Ven; Steve Bourgault; Normand Mousseau; Charles Ramassamy
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

Review 2.  Anti-hepatitis B activities of Myanmar medicinal plants: a narrative review of current evidence.

Authors:  Ye Htut Linn; Win Win Ei; Lwin Mon Mon Myint; Khin Maung Lwin
Journal:  Virusdisease       Date:  2021-07-14

3.  Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2.

Authors:  Rupesh V Chikhale; Saurabh K Sinha; Pukar Khanal; Nilambari S Gurav; Muniappan Ayyanar; Satyendra K Prasad; Manish M Wanjari; Rajesh B Patil; Shailendra S Gurav
Journal:  Phytomed Plus       Date:  2021-07-13

4.  Herbal products: benefits, limits, and applications in chronic liver disease.

Authors:  Anna Del Prete; Antonella Scalera; Maddalena Diana Iadevaia; Agnese Miranda; Claudio Zulli; Laura Gaeta; Concetta Tuccillo; Alessandro Federico; Carmelina Loguercio
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

Review 5.  The Genus Phyllanthus: An Ethnopharmacological, Phytochemical, and Pharmacological Review.

Authors:  Xin Mao; Ling-Fang Wu; Hong-Ling Guo; Wen-Jing Chen; Ya-Ping Cui; Qi Qi; Shi Li; Wen-Yi Liang; Guang-Hui Yang; Yan-Yan Shao; Dan Zhu; Gai-Mei She; Yun You; Lan-Zhen Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-20       Impact factor: 2.629

Review 6.  Medicinal Plants with Potential Inhibitory Bioactive Compounds against Coronaviruses.

Authors:  Olutayo Ademola Adeleye; Oluyemisi Adebowale Bamiro; Lateef Gbenga Bakre; Florence Olubola Odeleye; Modupe Nofisat Adebowale; Olufemi Lionel Okunye; Mariam Adeola Sodeinde; Adannaya Charity Adebona; Farid Menaa
Journal:  Adv Pharm Bull       Date:  2021-01-30

7.  Antihepatitis B virus activity of a protein-enriched fraction from housefly (Musca domestica) in a stable HBV-producing cell line.

Authors:  Xuemei Lu; Xiaobao Jin; Jie Wang; Fujiang Chu; Jiayong Zhu
Journal:  ScientificWorldJournal       Date:  2014-06-22

Review 8.  A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants.

Authors:  Johnson O Oladele; Ebenezer I Ajayi; Oyedotun M Oyeleke; Oluwaseun T Oladele; Boyede D Olowookere; Boluwaji M Adeniyi; Olu I Oyewole; Adenike T Oladiji
Journal:  Heliyon       Date:  2020-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.